Incomplete radiofrequency ablation following transarterial chemoembolization accelerates the progression of large hepatocellular carcinoma
Shangdong Mu, Qingjuan Chen, Shuo Li, Dongfeng Wang, Yongchang Zhao, Xiang Li, Wei Fu, Zhigang Fan, Shan Tian, Zeng Li- Radiology, Nuclear Medicine and imaging
- Oncology
- General Medicine
ABSTRACT
Purpose:
To examine post-operative progression and risk impact of insufficient radiofrequency ablation (RFA) following transarterial chemoembolization (TACE) for the prognosis of large hepatocellular carcinoma (HCC).
Materials and Methods:
From January 2014 to January 2021 were analyzed. A total of 343 patients with large HCC (diameter >5 cm) who received TACE combined with RFA were enrolled and were divided into two groups: complete ablation (CA,
Results:
The cumulative 1-, 3-, and 5-year OS and PFS rates of the CA group were significantly higher than that of the IA group (
Conclusion:
Insufficient ablation causes a poor survival outcome of TACE combined with RFA for large HCC, particularly, which can promote IDR.